Zdravka Medarova
Founder bij TRANSCODE THERAPEUTICS, INC.
Vermogen: 6 482 $ op 31-03-2024
Profiel
Zdravka Medarova is the founder of TransCode Therapeutics, Inc., a company founded in 2016.
She holds the title of Chief Scientific Officer at TransCode Therapeutics, Inc. Currently, Dr. Medarova is also working as an Associate Professor at Harvard Medical School since 2016.
Dr. Medarova obtained her doctorate degree from the University of New Hampshire in 2002 and her undergraduate degree from the University of Southern Maine in 1998.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CLS HOLDINGS USA INC
0.09% | 31-12-2023 | 96 639 ( 0.09% ) | 4 832 $ | 31-03-2024 |
| 13-12-2023 | 2 416 ( 0.04% ) | 1 650 $ | 31-03-2024 |
Actieve functies van Zdravka Medarova
| Bedrijven | Functie | Begin |
|---|---|---|
| TRANSCODE THERAPEUTICS, INC. | Founder | 01-01-2016 |
| Harvard Medical School | Corporate Officer/Principal | 01-04-2016 |
Opleiding van Zdravka Medarova
| University of New Hampshire | Doctorate Degree |
| University of Southern Maine | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| TRANSCODE THERAPEUTICS, INC. | Health Technology |
